Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis™, its innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.
Company profile
Ticker
WGS
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Former names
CM Life Sciences, Inc., Sema4 Holdings Corp.
SEC CIK
Corporate docs
Subsidiaries
Sema4 OpCo, Inc. • GeneDx, LLC ...
IRS number
851966622
WGS stock data
Latest filings (excl ownership)
424B5
Prospectus supplement for primary offering
30 Apr 24
8-K
Entry into a Material Definitive Agreement
29 Apr 24
424B5
Prospectus supplement for primary offering
29 Apr 24
ARS
2023 FY
Annual report to shareholders
29 Apr 24
DEFA14A
Additional proxy soliciting materials
29 Apr 24
DEF 14A
Definitive proxy
29 Apr 24
10-Q
2024 Q1
Quarterly report
29 Apr 24
8-K
GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
29 Apr 24
S-8
Registration of securities for employees
23 Feb 24
10-K
2023 FY
Annual report
23 Feb 24
Transcripts
WGS
Earnings call transcript
2024 Q1
29 Apr 24
WGS
Earnings call transcript
2023 Q4
20 Feb 24
WGS
Earnings call transcript
2023 Q3
30 Oct 23
WGS
Earnings call transcript
2023 Q2
8 Aug 23
WGS
Earnings call transcript
2023 Q1
9 May 23
WGS
Earnings call transcript
2022 Q4
14 Mar 23
WGS
Earnings call transcript
2022 Q3
14 Nov 22
WGS
Earnings call transcript
2022 Q2
16 Aug 22
WGS
Earnings call transcript
2022 Q2
15 Aug 22
WGS
Earnings call transcript
2022 Q1
13 May 22
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 88.29 mm | 88.29 mm | 88.29 mm | 88.29 mm | 88.29 mm | 88.29 mm |
Cash burn (monthly) | 23.09 mm | 9.79 mm | 14.32 mm | 40.05 mm | 13.74 mm | 17.91 mm |
Cash used (since last report) | 169.77 mm | 71.96 mm | 105.31 mm | 294.48 mm | 101.05 mm | 131.70 mm |
Cash remaining | -81.48 mm | 16.33 mm | -17.02 mm | -206.19 mm | -12.76 mm | -43.41 mm |
Runway (months of cash) | -3.5 | 1.7 | -1.2 | -5.1 | -0.9 | -2.4 |
Institutional ownership, Q4 2023
13F holders | Current |
---|---|
Total holders | 8 |
Opened positions | 0 |
Closed positions | 53 |
Increased positions | 0 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 580.19 mm |
Total shares | 1.38 bn |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
School Of Medicine At Mount Sinai Icahn | 1.23 bn | $523.26 mm |
OPK Opko Health | 117.43 mm | $34.15 mm |
Blackstone Holdings III | 27.80 mm | $11.81 mm |
CMLS | 3.10 mm | $3.99 mm |
Integrated Core Strategies | 1.28 mm | $5.71 mm |
Flynn James E | 1.25 mm | $0.00 |
Versant Capital Management | 455.00 | $1.25 mm |
Allworth Financial | 6.00 | $17.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 May 24 | Pfenniger Richard C JR | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 918 | 0.00 | 21,836 |
2 May 24 | Pfenniger Richard C JR | RSU Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 918 | 0.00 | 918 |
29 Apr 24 | Katherine Stueland | Class A Common Stock | Sell | Dispose S | No | No | 11.0368 | 6,325 | 69.81 k | 75,869 |
29 Apr 24 | Katherine Stueland | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 15,496 | 0.00 | 82,194 |
29 Apr 24 | Katherine Stueland | RSU Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 15,496 | 0.00 | 30,992 |
29 Apr 24 | Kevin Feeley | Class A Common Stock | Sell | Dispose S | No | No | 11.0368 | 1,104 | 12.18 k | 30,836 |
29 Apr 24 | Kevin Feeley | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 3,013 | 0.00 | 31,940 |
29 Apr 24 | Kevin Feeley | RSU Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 3,013 | 0.00 | 6,026 |
18 Mar 24 | Katherine Stueland | Class A Common Stock | Sell | Dispose S | No | No | 10.5925 | 8,559 | 90.66 k | 66,698 |
18 Mar 24 | Kareem Saad | Class A Common Stock | Sell | Dispose S | No | No | 10.5923 | 2,008 | 21.27 k | 29,517 |
News
Gold Down Over 2%; 3M Profit Beats Expectations
30 Apr 24
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
30 Apr 24
12 Health Care Stocks Moving In Tuesday's Intraday Session
30 Apr 24
TD Cowen Maintains Buy on GeneDx Hldgs, Raises Price Target to $24
30 Apr 24
Eli Lilly Increases FY24 Outlook, Joins Brinker International, Zebra Technologies, 3M And Other Big Stocks Moving Higher On Tuesday
30 Apr 24